These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
309 related articles for article (PubMed ID: 26546630)
1. IV thrombolysis in very severe and severe ischemic stroke: Results from the SITS-ISTR Registry. Mazya MV; Lees KR; Collas D; Rand VM; Mikulik R; Toni D; Wahlgren N; Ahmed N Neurology; 2015 Dec; 85(24):2098-106. PubMed ID: 26546630 [TBL] [Abstract][Full Text] [Related]
2. Results of intravenous thrombolysis within 4.5 to 6 hours and updated results within 3 to 4.5 hours of onset of acute ischemic stroke recorded in the Safe Implementation of Treatment in Stroke International Stroke Thrombolysis Register (SITS-ISTR): an observational study. Ahmed N; Kellert L; Lees KR; Mikulik R; Tatlisumak T; Toni D; JAMA Neurol; 2013 Jul; 70(7):837-44. PubMed ID: 23689267 [TBL] [Abstract][Full Text] [Related]
3. Intravenous thrombolysis in young stroke patients: results from the SITS-ISTR. Toni D; Ahmed N; Anzini A; Lorenzano S; Brozman M; Kaste M; Mikulik R; Putaala J; Wahlgren N; Neurology; 2012 Mar; 78(12):880-7. PubMed ID: 22402853 [TBL] [Abstract][Full Text] [Related]
4. Clinical Selection Strategies to Identify Ischemic Stroke Patients With Large Anterior Vessel Occlusion: Results From SITS-ISTR (Safe Implementation of Thrombolysis in Stroke International Stroke Thrombolysis Registry). Scheitz JF; Abdul-Rahim AH; MacIsaac RL; Cooray C; Sucharew H; Kleindorfer D; Khatri P; Broderick JP; Audebert HJ; Ahmed N; Wahlgren N; Endres M; Nolte CH; Lees KR; Stroke; 2017 Feb; 48(2):290-297. PubMed ID: 28087804 [TBL] [Abstract][Full Text] [Related]
5. Symptomatic intracranial hemorrhage following intravenous thrombolysis for acute ischemic stroke: a critical review of case definitions. Seet RC; Rabinstein AA Cerebrovasc Dis; 2012; 34(2):106-14. PubMed ID: 22868870 [TBL] [Abstract][Full Text] [Related]
6. Safety of intravenous thrombolysis for ischemic stroke in patients treated with warfarin. Mazya MV; Lees KR; Markus R; Roine RO; Seet RC; Wahlgren N; Ahmed N; Ann Neurol; 2013 Aug; 74(2):266-74. PubMed ID: 23744571 [TBL] [Abstract][Full Text] [Related]
7. Preclusion of ischemic stroke patients from intravenous tissue plasminogen activator treatment for mild symptoms should not be based on low National Institutes of Health Stroke Scale Scores. Wendt M; Tütüncü S; Fiebach JB; Scheitz JF; Audebert HJ; Nolte CH J Stroke Cerebrovasc Dis; 2013 May; 22(4):550-3. PubMed ID: 23433783 [TBL] [Abstract][Full Text] [Related]
8. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator. Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898 [TBL] [Abstract][Full Text] [Related]
9. Intravenous Thrombolysis in Unknown-Onset Stroke: Results From the Safe Implementation of Treatment in Stroke-International Stroke Thrombolysis Registry. Dorado L; Ahmed N; Thomalla G; Lozano M; Malojcic B; Wani M; Millán M; Tomek A; Dávalos A Stroke; 2017 Mar; 48(3):720-725. PubMed ID: 28174326 [TBL] [Abstract][Full Text] [Related]
10. Aphasia predicts unfavorable outcome in mild ischemic stroke patients and prompts thrombolytic treatment. Nesi M; Lucente G; Nencini P; Fancellu L; Inzitari D J Stroke Cerebrovasc Dis; 2014 Feb; 23(2):204-8. PubMed ID: 23352114 [TBL] [Abstract][Full Text] [Related]
11. Intravenous thrombolysis for patients with in-hospital stroke onset: propensity-matched analysis from the Safe Implementation of Treatments in Stroke-East registry. Tsivgoulis G; Katsanos AH; Kadlecová P; Czlonkowska A; Kobayashi A; Brozman M; Švigelj V; Csiba L; Fekete K; Kõrv J; Demarin V; Vilionskis A; Jatuzis D; Krespi Y; Karapanayiotides T; Giannopoulos S; Mikulik R Eur J Neurol; 2017 Dec; 24(12):1493-1498. PubMed ID: 28888075 [TBL] [Abstract][Full Text] [Related]
12. Thrombolytic therapy for acute stroke in the United Kingdom: experience from the safe implementation of thrombolysis in stroke (SITS) register. Lees KR; Ford GA; Muir KW; Ahmed N; Dyker AG; Atula S; Kalra L; Warburton EA; Baron JC; Jenkinson DF; Wahlgren NG; Walters MR; QJM; 2008 Nov; 101(11):863-9. PubMed ID: 18694900 [TBL] [Abstract][Full Text] [Related]
13. Hyperdense middle cerebral artery sign on admission CT scan--prognostic significance for ischaemic stroke patients treated with intravenous thrombolysis in the safe implementation of thrombolysis in Stroke International Stroke Thrombolysis Register. Kharitonova T; Ahmed N; Thorén M; Wardlaw JM; von Kummer R; Glahn J; Wahlgren N Cerebrovasc Dis; 2009; 27(1):51-9. PubMed ID: 19018138 [TBL] [Abstract][Full Text] [Related]
15. The THRIVE score predicts symptomatic intracerebral hemorrhage after intravenous tPA administration in SITS-MOST. Flint AC; Gupta R; Smith WS; Kamel H; Faigeles BS; Cullen SP; Rao VA; Bath PM; Wahlgren N; Ahmed N; Donnan GA; Int J Stroke; 2014 Aug; 9(6):705-10. PubMed ID: 25042855 [TBL] [Abstract][Full Text] [Related]
16. Intravenous recombinant tissue plasminogen activator for acute stroke in Poland: an analysis based on the Safe Implementation of Thrombolysis in Stroke (SITS) Registry. Kobayashi A; Czlonkowska A; Ahmed N; Romanowicz S; Glonek M; Nyka WM; Opala G; Wahlgren N; Acta Neurol Scand; 2010 Oct; 122(4):229-36. PubMed ID: 19919643 [TBL] [Abstract][Full Text] [Related]
17. Two tales: hemorrhagic transformation but not parenchymal hemorrhage after thrombolysis is related to severity and duration of ischemia: MRI study of acute stroke patients treated with intravenous tissue plasminogen activator within 6 hours. Thomalla G; Sobesky J; Köhrmann M; Fiebach JB; Fiehler J; Zaro Weber O; Kruetzelmann A; Kucinski T; Rosenkranz M; Röther J; Schellinger PD Stroke; 2007 Feb; 38(2):313-8. PubMed ID: 17204683 [TBL] [Abstract][Full Text] [Related]
18. Intravenous thrombolysis for acute ischemic stroke associated to extracranial internal carotid artery occlusion: the ICARO-2 study. Paciaroni M; Agnelli G; Caso V; Pieroni A; Bovi P; Cappellari M; Zini A; Nichelli P; Inzitari D; Nesi M; Nencini P; Pezzini A; Padovani A; Tassinari T; Orlandi G; Chiti A; Gialdini G; Alberti A; Venti M; Acciarresi M; D'Amore C; Luda E; Tassi R; Martini G; Ferrarese C; Beretta S; Trentini C; Silvestrelli G; Lanari A; Previdi P; Ciccone A; Delodovici ML; Bono G; Galletti G; Marcheselli S; Del Sette M; Traverso E; Riva M; Silvestrini M; Cerqua R; Consoli D; Monaco S; Toni D Cerebrovasc Dis; 2012; 34(5-6):430-5. PubMed ID: 23207482 [TBL] [Abstract][Full Text] [Related]
19. Implementation and outcome of thrombolysis with alteplase 3-4.5 h after an acute stroke: an updated analysis from SITS-ISTR. Ahmed N; Wahlgren N; Grond M; Hennerici M; Lees KR; Mikulik R; Parsons M; Roine RO; Toni D; Ringleb P; Lancet Neurol; 2010 Sep; 9(9):866-74. PubMed ID: 20667790 [TBL] [Abstract][Full Text] [Related]